The analysis identified key factors contributing to postoperative BM risk, including ALP levels, Gleason Score, ECE invasion, pathological tumor volume, and both preoperative and postoperative PSA levels (see Figures 5A–D). The gene discussed is KLK3; the disease is neoplasm.